McDermott Will & Emery has advised TreeFrog Therapeutics on the deal. TreeFrog Therapeutics, a French biotech company aiming to unlock access to cell therapies for millions...
TreeFrog Therapeutics’ Licensing Agreement with Vertex
MiddleGround Capital’s Acquisition of A.M. Castle & Co
McDermott Will & Emery represented A.M. Castle & Co. in the transaction. A.M. Castle & Co., a leading provider of metals, services and supply chain solutions...
Novo Nordisk’s EUR154 Million Acquisition of a Majority Stake in Biocorp
McDermott advised Biocorp Production SA on its proposed acquisition by Novo Nordisk, while Novo Nordisk A/S was advised by Bird & Bird. Novo Nordisk A/S and...
Luxempart Group’s Acquisition of a Minority Stake in Kestrel Vision
PwC advised Kestrel Vision. Ashurst advised Caravelle. McDermott Will & Emery advised Luxempart. Kestrel Vision, a global leader in glass control and inspection, has begun a...
Brown-Forman’s Acquisition of Diplomático Rum
Cuatrecasas advised the US Brown-Forman Corporation on the deal, while McDermott Will & Emery represented Destillers United Group. US Brown-Forman Corporation acquired the companies in the...
CMA CGM’s Acquisition of GEFCO
Darrois Villey Maillot Brochier, McDermott and Willkie Farr advised GEFCO on the deal. Gefco, the European leader in automotive logistics and an international expert in multimodal...
Argos Wityu’s Acquisition of FEDD, Leroy Automation, Phenix Electronique, Team 31 and DMA
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised Argos Wityu with a team including Gr?oire Andrieux (Picture – Corporate...
Argos Wityu’s Acquisition of FEDD, Leroy Automation, Phenix Electronique, Team 31 and DMAI (MCC)
McDermott Will & Emery and Arsene Taxand advised Argos Wityu on the deal. Argos Wityu, an independent European investment fund, executed the acquisition of a majority...
uniQure’s Acquisition of Corlieve Therapeutics
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...